(Q45343506)

13 December 2017

title

Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques (English)

1 reference

13 December 2017

1 reference

3

1 reference

13 December 2017

4

1 reference

13 December 2017

5

1 reference

13 December 2017

10

1 reference

13 December 2017

Judit Marsillach

1

1 reference

13 December 2017

Jordi Camps

2

1 reference

13 December 2017

Carmen Maestre-Martínez

6

1 reference

13 December 2017

Fàtima Sabench

7

1 reference

13 December 2017

Mercè Hernández

8

1 reference

13 December 2017

Daniel D Castillo

9

1 reference

13 December 2017

Mike Mackness

11

1 reference

13 December 2017

Bharti Mackness

12

1 reference

13 December 2017

publication date

21 October 2010

1 reference

European Journal of Clinical Investigation

13 December 2017

published in

1 reference

13 December 2017

volume

41

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

308-314

1 reference

The paraoxonases: role in human diseases and methodological difficulties in measurement.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Pharmacogenetics of paraoxonases: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02411.X

10.1111/J.1365-2362.2010.02411.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference